Yüklüyor......
Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals
Meso-tetra-hydroxyphenyl-chlorin (mTHPC, Foscan®), a promising photosensitizer for photodynamic therapy (PDT), is approved in Europe for the palliative treatment of head and neck cancer. Based on work in mice that investigated optimal tumor accumulation, clinical protocols with Foscan® typically emp...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Association of Physicists in Medicine
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2562246/ https://ncbi.nlm.nih.gov/pubmed/18777912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1118/1.2952360 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|